Kiora Pharmaceuticals, Inc. (KPRX)

Kiora Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31.28	2.46	6.01	7.9	1.23	3.82
Cash & Cash Equivalents	31.28	2.46	6.01	7.9	1.23	3.82
Cash Growth	811.90%	-59.11%	-23.87%	541.90%	-67.80%	-52.52%
Receivables	0.19	0	0	0	0.09	0
Other Current Assets	2.01	2.28	1.67	1.09	0.4	0.5
Total Current Assets	33.48	4.74	7.68	8.99	1.73	4.32
Property, Plant & Equipment	0.11	0.11	0.17	0.28	0.11	0.1
Goodwill and Intangibles	8.81	8.81	10.74	10.77	13.36	5.66
Other Long-Term Assets	0.04	0.05	0.08	0.09	0.1	0.03
Total Long-Term Assets	8.96	8.97	11	11.14	13.58	5.79
Total Assets	42.44	13.71	18.68	20.13	15.3	10.11
Accounts Payable	0.32	0.21	1.01	0.16	0.43	0.21
Current Debt	0.05	0.05	0.11	0.12	0.26	0.08
Other Current Liabilities	1.22	1.38	2.16	1.33	1.29	1.12
Total Current Liabilities	1.59	1.63	3.27	1.61	1.98	1.41
Long-Term Debt	0.05	0.06	0	0.09	0.31	0
Other Long-Term Liabilities	5.9	5.91	4	3.85	3.28	2.08
Total Long-Term Liabilities	5.94	5.97	4	3.94	3.59	2.08
Total Liabilities	7.54	7.6	7.27	5.55	5.57	3.49
Total Debt	0.09	0.11	0.11	0.21	0.57	0.08
Debt Growth	28.67%	1.05%	-49.49%	-63.54%	584.41%	-
Retained Earnings	-133.52	-146.98	-134.46	-120.88	-107.11	-100.25
Comprehensive Income	-0.26	-0.18	-0.18	-0.09	-0	0.14
Shareholders' Equity	34.9	6.11	11.41	14.58	9.73	6.62
Net Cash / Debt	31.19	2.35	5.91	7.69	0.66	3.74
Net Cash / Debt Growth	829.00%	-60.19%	-23.18%	1071.80%	-82.44%	-53.56%
Net Cash Per Share	8.01	4.37	72.61	287.07	51.46	423.02
Working Capital	31.89	3.1	4.41	7.38	-0.26	2.91
Book Value Per Share	12.11	11.36	140.20	544.22	762.87	749.47

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).